Development of a Human Leukocyte Antigen Score to Predict Progression-Free Survival in Head and Neck Squamous Cell Carcinoma Patients
BackgroundIn personalized medicine and treatment stratification of head and neck squamous cell carcinoma (HNSCC), the heterogeneous genetic background of patients is not considered. Human leukocyte antigen (HLA) alleles and HLA haplotypes (HLA traits) are linked to development of HNSCC and affect pr...
Main Authors: | Gunnar Wichmann, Claudia Lehmann, Cindy Herchenhahn, Marlen Kolb, Mathias Hofer, Susanne Wiegand, Andreas Dietz |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-05-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2018.00168/full |
Similar Items
-
Laryngeal Preservation Approaches: Considerations for New Selection Criteria Based on the DeLOS-II Trial
by: Andreas Dietz, et al.
Published: (2019-07-01) -
Overview of Human Leukocyte Antigen Development at Siriraj Hospital
by: Dasnayanee Chandanayingyong
Published: (2017-02-01) -
Pre-Therapeutic VEGF Level in Plasma Is a Prognostic Bio-Marker in Head and Neck Squamous Cell Carcinoma (HNSCC)
by: Julia Siemert, et al.
Published: (2021-07-01) -
Metabolism of acetate by human leukocytes
by: Pastore, Edward Joseph
Published: (2017) -
Two probable human leukocyte antigen haplotypes in association with human leukocyte antigen HLA-DRB1*13:50:01 identified in 41 randomized unrelated Taiwanese individuals
by: Nondumiso Ayanda Mazibuko, et al.
Published: (2021-01-01)